IRIS UniCatt

Marino, Mariapaola
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.603
AS - Asia 3.085
EU - Europa 2.424
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 201
AF - Africa 101
OC - Oceania 16
Totale 12.084
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.334
SG - Singapore 1.431
CN - Cina 663
SE - Svezia 554
BR - Brasile 527
IT - Italia 492
DE - Germania 339
VN - Vietnam 284
FR - Francia 266
GB - Regno Unito 142
IE - Irlanda 130
CA - Canada 127
IN - India 123
BD - Bangladesh 113
JP - Giappone 91
RU - Federazione Russa 91
ID - Indonesia 85
UA - Ucraina 82
FI - Finlandia 76
PL - Polonia 66
HK - Hong Kong 63
MX - Messico 56
AR - Argentina 41
ES - Italia 35
NL - Olanda 33
TR - Turchia 31
IQ - Iraq 30
ZA - Sudafrica 30
BE - Belgio 29
KR - Corea 27
CO - Colombia 26
AT - Austria 18
EC - Ecuador 18
IL - Israele 18
MA - Marocco 17
CR - Costa Rica 16
PK - Pakistan 14
SC - Seychelles 14
UZ - Uzbekistan 14
VE - Venezuela 14
CH - Svizzera 13
SA - Arabia Saudita 13
CI - Costa d'Avorio 12
CL - Cile 10
GT - Guatemala 10
HN - Honduras 10
IR - Iran 10
JO - Giordania 10
PR - Porto Rico 10
AU - Australia 9
CZ - Repubblica Ceca 9
JM - Giamaica 8
KE - Kenya 8
MY - Malesia 8
PH - Filippine 8
SV - El Salvador 8
LT - Lituania 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
BY - Bielorussia 6
LB - Libano 6
NI - Nicaragua 6
PY - Paraguay 6
TN - Tunisia 6
AL - Albania 5
DK - Danimarca 5
KZ - Kazakistan 5
OM - Oman 5
BO - Bolivia 4
CW - ???statistics.table.value.countryCode.CW??? 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
EG - Egitto 4
NO - Norvegia 4
PT - Portogallo 4
TH - Thailandia 4
UY - Uruguay 4
GR - Grecia 3
HU - Ungheria 3
KG - Kirghizistan 3
LK - Sri Lanka 3
PA - Panama 3
PE - Perù 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AZ - Azerbaigian 2
BB - Barbados 2
GA - Gabon 2
GD - Grenada 2
GP - Guadalupe 2
LV - Lettonia 2
NP - Nepal 2
TM - Turkmenistan 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BG - Bulgaria 1
BH - Bahrain 1
Totale 11.871
Salva come PNG Salva come JPEG
Città #
Singapore 849
Ashburn 742
Chandler 532
San Jose 470
New York 175
Council Bluffs 170
Los Angeles 151
Beijing 145
Dublin 129
Rome 111
Dallas 105
Ho Chi Minh City 99
North Bergen 95
San Mateo 89
Tokyo 88
The Dalles 84
Hefei 77
Jakarta 76
Lauterbourg 72
Santa Clara 69
Milan 67
Hanoi 65
Chicago 61
Boston 60
Frankfurt am Main 59
Hong Kong 58
Jacksonville 56
São Paulo 56
Marseille 52
Wilmington 50
Cattolica 49
Munich 49
Princeton 46
Ann Arbor 45
Cambridge 45
Orem 45
Moscow 44
Helsinki 42
Houston 42
Boardman 38
Bremen 35
Phoenix 33
Redwood City 33
Denver 32
Montreal 32
Warsaw 31
Atlanta 30
Paris 28
Buffalo 27
Dearborn 27
Toronto 27
Woodbridge 26
Nanjing 25
Seattle 25
Brooklyn 24
San Francisco 24
Chennai 23
Hyderabad 23
Seoul 23
Brussels 22
Kent 22
London 21
Da Nang 19
Johannesburg 19
Nuremberg 19
Rio de Janeiro 19
Stockholm 19
Bologna 18
Kraków 17
Amsterdam 15
Baghdad 15
Falls Church 15
Norwalk 15
San Diego 15
Charlotte 13
Dhaka 13
Lappeenranta 13
Manchester 13
Mexico City 13
Naples 13
Philadelphia 13
Querétaro 13
Washington 13
Abidjan 12
Des Moines 12
Newark 12
Brasília 11
Falkenstein 11
Tashkent 11
Turku 11
Carrboro 10
City of London 10
Columbus 10
Edinburgh 10
Fairfield 10
Las Vegas 10
Lawrence 10
Poplar 10
Quito 10
Amman 9
Totale 6.451
Salva come PNG Salva come JPEG
Nome #
Alterazioni delle risposte immuno-infiammatorie nei pazienti affetti da disturbo depressivo maggiore (Immune-inflammatory response changes in patients with major depressive disorder) 309
PTPN22 and myasthenia gravis: replication in an Italian population and meta-analysis of literature data 253
Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets 242
T cell repertoire in DQ5-positive MuSK-positive myasthenia gravis patients 218
A Study of Inflammatory/Necrosis Biomarkers in the Fracture of the Femur Treated with Proximal Femoral Nail Antirotation 213
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 213
Flow Cytofluorimetric Analysis of Anti-LRP4 (LDL Receptor-Related Protein 4) Autoantibodies in Italian Patients with Myasthenia Gravis 202
Low reliability of anti-KIR4.183-120 peptide auto-antibodies in multiple sclerosis patients 201
Human Leukocyte Antigen Class II associations in late-onset Myasthenia Gravis 198
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 196
Immunological role of IgG subclasses 191
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 191
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 190
HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. 183
IL-6 regulates MCP-1, ICAM-1 and IL-6 expression in human myoblasts. 181
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 181
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 175
Myasthenia gravis with antibodies to MuSK: an update 174
Skeletal muscle cells: from local inflammatory response to active immunity 170
Low reliability of anti-KIR4.183–120peptide auto-antibodies in multiple sclerosis patients 170
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 169
Anti-Inflammatory Effects of Curcumin-Based Nanoparticles Containing α-Linolenic Acid in a Model of Psoriasis In Vitro 169
Acetylcholine receptor antibody positivity rate in ocular myasthenia gravis: a matter of age? 167
Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy 164
Fluidi ed elettroliti. Equilibrio acido-base 164
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 161
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 160
Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis. 157
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 155
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 154
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 154
Exploratory study of extracellular matrix biomarkers for non-invasive liver fibrosis staging: A machine learning approach with XGBoost and explainable AI 152
A comparative study of serum angiogenic biomarkers in cirrhosis and hepatocellular carcinoma 152
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 151
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 151
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 150
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 148
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 148
Epidemiological evidence for a hereditary contribution to myasthenia gravis: A retrospective cohort study of patients from North America 148
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 147
Immunological role of IgG subclasses 145
Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis 145
Evaluation of free light chains of immunoglobulins in normal and pathological seminal fluids: Preliminary data 144
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 143
Increased Complement Activation in Systemic Sclerosis Patients with Skin and Lung Fibrosis 143
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 141
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 141
Rituximab in myasthenia gravis: a "to be or not to be" inhibitor of T cell function 140
Serum levels of free light chains and syndecan-1 in patients with rheumatoid arthritis and systemic lupus erythematosus 139
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 134
The Laboratory Role in anti-TNF Biological Therapy Era 133
Serum Immunoglobulin G (IgG) Subclasses in a Cohort of Systemic Sclerosis Patients 131
Anti-MuSK antibodies: Correlation with myasthenia gravis severity 131
The dark side of current analytic methods for Bence Jones Proteinuria 128
The Effect of SARS-CoV-2 Vaccination on B-Cell Phenotype in Systemic Sclerosis Patients 126
Distinct Biomarker Profiles of B-Cell Activation in Metabolic and Viral Hepatic Fibrosis 126
Tumor necrosis factor-alpha: ally and enemy in protean cutaneous sceneries 123
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 122
Free light chains and autoimmunity 120
Cryoglobulins: putative effectors of adaptive immune response 117
IL-6, monocyte infiltration and parenchymal cells 117
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 117
Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes 114
Cryoproteins in Non-HCV-Related Autoimmune Disorders: A Serious Cold-Induced Problem 112
Effect of pro-inflammatory/anti-inflammatory agents on cytokine secretion by peripheral blood mononuclear cells in rheumatoid arthritis and systemic lupus erythematosus 110
New Biomarkers in Liver Fibrosis: A Pass through the Quicksand? 108
Anti-P110 autoantibodies identify a subtype of "seronegative" myasthenia gravis with prominent oculobulbar involvement 107
Type 2 cytokines and scleroderma interstitial lung disease 105
Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker? 101
Calprotectin: two sides of the same coin 99
The Evolution of Serological Assays during Two Years of the COVID-19 Pandemic: From an Easy-to-Use Screening Tool for Identifying Current Infections to Laboratory Algorithms for Discovering Immune Protection and Optimizing Vaccine Administration 97
A new challenge for urinary free light chains: assessment of the upper reference limit in healthy subjects 97
Identification of disease-specific autoantibodies in seronegative myasthenia gravis 96
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 95
Immune-inflammatory response changes in patients with major depressive disorder 94
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 92
In Systemic Sclerosis Patients, Peripheral Blood CD21low B Cells and Serum IL-4 and IL-21 Influence Joint Involvement 88
Anti-adalimumab and anti-certolizumab antibodies titers after discontinuation of adalimumab: Two case reports 85
Constitutive and cytokine-induced expression of MHC and intercellular adhesion molecule-1 (ICAM-1) on human myoblasts 85
Assessment of Cardiorenal Involvement in Systemic Sclerosis Patients 82
Serum Adiponectin, a Novel Biomarker Correlates with Skin Thickness in Systemic Sclerosis 75
TGF-β1 and IL-10 modulate IL-1β-induced membrane and soluble ICAM-1 in human myoblasts 64
IgA Subclasses and Free Light Chains in Celiac Disease: A Pilot Study 43
Cryoglobulinemia and Cryofibrinogenemia: Ten years of experience and diagnostic perspectives from a large laboratory-based cohort 31
Autoimmune and Inflammatory Diseases: Identifying New Advances in Immunological Insights 26
Totale 12.084
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.769
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.769
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022485 0 0 0 0 56 21 12 98 32 26 103 137
2022/20231.491 223 198 94 236 69 163 84 140 155 28 70 31
2023/2024852 35 180 19 89 33 131 54 35 13 51 91 121
2024/20251.866 75 68 131 66 143 85 51 110 308 157 386 286
2025/20264.755 579 121 324 682 901 227 823 260 250 298 140 150
2026/20271.688 172 286 373 643 214 0 0 0 0 0 0 0
Totale 12.084